Activation of p38 MAPK by oxidative stress underlying epirubicin-induced vascular endothelial cell injury.


Epirubicin, an anthracycline antitumor drug, often causes vascular injury such as vascular pain, phlebitis, and necrotizing vasculitis. However, an effective prevention for the epirubicin-induced vascular injury has not been established. The purpose of this study is to identify the mechanisms of cell injury induced by epirubicin in porcine aorta endothelial… (More)
DOI: 10.1016/j.freeradbiomed.2012.02.003


8 Figures and Tables